BCAX - Bicara Therapeutics Inc. Common Stock
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$28.60
DETAILS
HIGH:
$42.00
LOW:
$18.00
MEDIAN:
$28.00
CONSENSUS:
$28.60
UPSIDE:
31.92%
| Metric | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | |||||||||||||
| R&D Expenses | 47.5 | 33.0 | 5.8 | 24.8 | 34.3 | 19.9 | 15.9 | 15.8 | 12.0 | 10.6 | 6.9 | 6.6 | 6.6 |
| SG&A Expenses | 12.7 | 8.1 | 7.7 | 7.2 | 7.5 | 6.8 | 4.8 | 3.9 | 3.3 | 3.1 | 2.6 | 1.8 | 1.8 |
| Other Expenses | 0 | 0 | 27.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 60.2 | 41.1 | 40.7 | 32.0 | 41.8 | 26.6 | 20.6 | 19.8 | 15.4 | 13.7 | 9.5 | 8.3 | 8.3 |
| Operating Income | |||||||||||||
| Operating Income | (60.2) | (41.1) | (40.7) | (32.0) | (41.8) | (26.6) | (20.6) | (19.8) | (15.4) | (13.7) | (9.5) | (8.3) | (8.3) |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 4.1 | 3.8 | 4.4 | 4.7 | 5.0 | 5.9 | 3.1 | 2.7 | 2.9 | 1.3 | 0.0 | 0 | 0 |
| Profitability | |||||||||||||
| EBITDA | (60.2) | (41.1) | (36.2) | (32.0) | (41.8) | (26.6) | (20.6) | (19.7) | (15.4) | (25.8) | (9.5) | (8.3) | (8.3) |
| EBIT | (60.2) | (41.1) | (36.3) | (32.0) | (41.8) | (26.6) | (20.6) | (19.8) | (15.4) | (25.8) | (9.5) | (8.3) | (8.3) |
| Income Before Tax | (56.2) | (37.3) | (36.3) | (27.3) | (36.8) | (20.8) | (17.5) | (17.0) | (12.5) | (12.4) | (22.8) | (8.3) | (8.3) |
| Income Tax Expense | (0.1) | 0.1 | 0.0 | 0.1 | 0.1 | 0.2 | 0 | 0 | 0.0 | 0.0 | 0 | 0 | 0 |
| Net Income | (56.2) | (37.4) | (36.3) | (27.4) | (36.8) | (21.0) | (17.5) | (17.0) | (12.5) | (12.4) | (22.8) | (8.3) | (8.3) |
| Per Share Data | |||||||||||||
| EPS (Basic) | -0.93 | -0.68 | -0.67 | -0.50 | -0.68 | -0.38 | -0.32 | -0.27 | -0.27 | -0.23 | -0.42 | -0.15 | -0.15 |
| EPS (Diluted) | -0.93 | -0.68 | -0.67 | -0.50 | -0.68 | -0.38 | -0.32 | -0.27 | -0.27 | -0.23 | -0.42 | -0.15 | -0.15 |
| Shares Outstanding | 60.7 | 55.1 | 54.6 | 54.5 | 54.5 | 54.4 | 54.4 | 54.2 | 54.2 | 53.1 | 54.4 | 54.6 | 54.6 |
| Metric | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | |||||||||||
| Cash & Cash Equivalents | 323.5 | 96.7 | 171.7 | 436.6 | 462.1 | 489.7 | 520.8 | 203.9 | 203.9 | 230.4 | 0 |
| Short-Term Investments | 216.3 | 318.1 | 118.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 5.2 | 7.3 | 7.2 | 0 | 8.7 | 12.8 | 0 | 2.2 | 0 | 0.1 | (4.2) |
| Total Current Assets | 544.9 | 422.1 | 297.4 | 444.4 | 470.8 | 502.5 | 521.5 | 206.1 | 206.1 | 231.1 | 0 |
| Non-Current Assets | |||||||||||
| Property, Plant & Equipment | 1.8 | 2.0 | 2.1 | 2.4 | 0.7 | 0.8 | 0.5 | 0.6 | 0.6 | 0.8 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 117.4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 6.9 | 6.9 | 7.8 | 6.8 | 6.6 | 6.6 | 2.1 | 2.1 | 2.1 | 2.1 | 0 |
| Total Non-Current Assets | 8.7 | 8.9 | 127.3 | 9.2 | 7.3 | 66.7 | 2.7 | 2.7 | 2.7 | 2.9 | 0 |
| Total Assets | 553.6 | 431.0 | 424.7 | 453.6 | 478.1 | 569.2 | 524.2 | 208.8 | 208.8 | 234.0 | 0 |
| Current Liabilities | |||||||||||
| Account Payables | 6.2 | 5.5 | 3.0 | 2.9 | 2.7 | 4.5 | 2.0 | 4.7 | 4.7 | 3.2 | 0 |
| Short-Term Debt | 1.1 | 1.1 | 1.1 | 0 | 0 | 0.6 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 32.0 | 22.3 | 16.9 | 0 | 1.7 | 9.8 | 0 | 1.1 | 0 | 0 | 0 |
| Total Current Liabilities | 39.3 | 28.9 | 21.0 | 17.2 | 19.1 | 18.0 | 14.5 | 16.1 | 16.1 | 15.1 | 0 |
| Non-Current Liabilities | |||||||||||
| Long-Term Debt | 0.3 | 0.6 | 0.9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 59.2 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 367.3 | 0 | 0.0 | 17.3 |
| Total Non-Current Liabilities | 0.3 | 0.6 | 0.9 | 1.2 | 0 | 59.3 | 0.1 | 367.5 | 0.2 | 0.4 | 17.3 |
| Total Liabilities | 39.6 | 29.5 | 21.9 | 18.4 | 19.1 | 77.3 | 14.6 | 383.6 | 16.3 | 15.5 | 17.3 |
| Stockholders' Equity | |||||||||||
| Common Stock | 0.0 | 0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0 |
| Retained Earnings | (415.2) | 0 | (321.6) | (285.2) | (257.9) | (221.0) | (200.1) | (182.6) | (182.6) | (153.0) | 0 |
| Accumulated Other Comprehensive Income | (0.2) | 0 | (0.1) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (98.8) |
| Total Stockholders' Equity | 514.0 | 401.5 | 402.8 | 435.2 | 459.0 | 491.9 | 509.6 | (174.8) | 192.5 | 218.5 | (17.3) |
| Total Liabilities & Equity | 553.6 | 431.0 | 424.7 | 453.6 | 478.1 | 569.2 | 524.2 | 208.8 | 208.8 | 234.0 | 0 |
| Debt Metrics | |||||||||||
| Total Debt | 1.4 | 1.7 | 2.0 | 2.2 | 0.6 | 0.7 | 0.4 | 0.5 | 0.5 | 0.7 | 0 |
| Net Debt | (322.0) | (95.0) | (169.7) | (434.4) | (461.5) | (489.0) | (520.3) | (203.3) | (203.3) | (229.8) | 0 |
| Metric | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||
| Net Income | (56.2) | (37.4) | (36.3) | (27.4) | (36.8) | (21.0) | (17.5) | (17.0) | (12.5) | (12.4) | (22.8) | (8.3) | (8.3) |
| Depreciation & Amortization | 0 | 0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Stock-Based Compensation | 0 | 4.4 | 3.6 | 3.5 | 3.5 | 3.2 | 2.0 | 1.0 | 1.1 | 0.8 | 0.5 | 0.3 | 0.3 |
| Change in Working Capital | 12.2 | 8.4 | 3.2 | (1.9) | 5.1 | (12.0) | (1.9) | 3.0 | (3.3) | 2.9 | (1.6) | (0.4) | (0.4) |
| Other Non-Cash Items | 6.5 | 0.3 | 0.3 | 0.2 | 0.1 | (0.3) | 0.1 | 0.1 | 0.1 | 0.7 | 13.4 | (5.0) | (5.0) |
| Operating Cash Flow | (37.5) | (23.9) | (29.2) | (25.6) | (28.1) | (30.0) | (17.2) | (12.9) | (14.6) | (8.0) | (10.5) | (13.5) | (13.5) |
| Investing Activities | |||||||||||||
| Capital Expenditure | (0.1) | (0.2) | (0.0) | 0 | 0 | (0.0) | (0.0) | (0.0) | (0.0) | (0.4) | (0.1) | 0 | 0 |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | (82.1) | (236.1) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales/Maturities of Investments | 101 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.1 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | 100.9 | (82.3) | (236.1) | 0 | 0 | (0.0) | (0.0) | (0.0) | 0.1 | (0.4) | (0.1) | 0 | 0 |
| Financing Activities | |||||||||||||
| Net Debt Issuance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | 0 | 0 | 0 | 0.1 | 0 | 0 | 0.1 | 0 | 0.1 | 18.9 | 18.9 |
| Financing Cash Flow | 163.3 | 31.2 | 0.4 | 0.1 | 0.5 | (1.0) | 334.1 | 0.7 | 0.1 | 194.7 | 39.9 | 18.9 | 18.9 |
| Cash Position | |||||||||||||
| Net Change in Cash | 226.8 | (75.0) | (264.9) | (25.5) | (27.6) | (31.0) | 316.9 | 203.9 | (14.4) | 186.2 | 29.2 | 15.0 | 0 |
| Cash at Beginning | 96.7 | 171.7 | 436.6 | 462.1 | 489.7 | 520.8 | 203.9 | 0 | 230.4 | 44.2 | 15.0 | 0 | 0 |
| Cash at End | 323.5 | 96.7 | 171.7 | 436.6 | 462.1 | 489.7 | 520.8 | 203.9 | 216.0 | 230.4 | 44.2 | 15.0 | 0 |
| Free Cash Flow | (37.6) | (24.1) | (29.3) | (25.6) | (28.1) | (30.1) | (17.2) | (12.9) | (14.6) | (8.5) | (10.7) | (13.5) | (13.5) |
| Key Metrics | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | (60.2) | (41.1) | (40.7) | (32.0) | (41.8) | (26.6) | (20.6) | (19.8) | (15.4) | (13.7) | (9.5) | (8.3) | (8.3) |
| Net Income | (56.2) | (37.4) | (36.3) | (27.4) | (36.8) | (21.0) | (17.5) | (17.0) | (12.5) | (12.4) | (22.8) | (8.3) | (8.3) |
| EPS (Diluted) | -0.93 | -0.68 | -0.67 | -0.50 | -0.68 | -0.38 | -0.32 | -0.27 | -0.27 | -0.23 | -0.42 | -0.15 | -0.15 |
| Balance Sheet | |||||||||||||
| Cash & Equivalents | 323.5 | 96.7 | 171.7 | 436.6 | 462.1 | 489.7 | 520.8 | 203.9 | 203.9 | 230.4 | 0 | ||
| Total Assets | 553.6 | 431.0 | 424.7 | 453.6 | 478.1 | 569.2 | 524.2 | 208.8 | 208.8 | 234.0 | 0 | ||
| Total Debt | 1.4 | 1.7 | 2.0 | 2.2 | 0.6 | 0.7 | 0.4 | 0.5 | 0.5 | 0.7 | 0 | ||
| Stockholders' Equity | 514.0 | 401.5 | 402.8 | 435.2 | 459.0 | 491.9 | 509.6 | (174.8) | 192.5 | 218.5 | (17.3) | ||
| Cash Flow | |||||||||||||
| Operating Cash Flow | (37.5) | (23.9) | (29.2) | (25.6) | (28.1) | (30.0) | (17.2) | (12.9) | (14.6) | (8.0) | (10.5) | (13.5) | (13.5) |
| Capital Expenditure | (0.1) | (0.2) | (0.0) | 0 | 0 | (0.0) | (0.0) | (0.0) | (0.0) | (0.4) | (0.1) | 0 | 0 |
| Free Cash Flow | (37.6) | (24.1) | (29.3) | (25.6) | (28.1) | (30.1) | (17.2) | (12.9) | (14.6) | (8.5) | (10.7) | (13.5) | (13.5) |